MIR5188: A Potential Drug Target and Biomarker for Obesity (G100847004)

Target Name: MIR5188

NCBI ID: G100847004

MIR5188

Other Name(s): microRNA 5188 | hsa-miR-5188 | MicroRNA 5188 | hsa-mir-5188 | mir-5188

MIR5188: A Potential Drug Target and Biomarker for Obesity

Obesity is a significant public health issue, with over 20% of adults worldwide classified as obese or overweight. The increasing prevalence of obesity is associated with an array of health problems, including cardiovascular disease, diabetes, and certain cancers. The muscle mass and bone density reducing that occurs with aging also contribute to the rising prevalence of obesity.

MIR5188 is a protein that has been identified as a potential drug target and biomarker for obesity. It is located in the muscle and is involved in the regulation of muscle mass and bone density. MIR5188 has been shown to play a critical role in the development and maintenance of muscle mass, and it has been shown to also play a role in bone density.

Research has shown that individuals with higher MIR5188 levels are more likely to be overweight or obese. This is because MIR5188 is a key regulator of muscle mass and bone density, and higher levels of MIR5188 in the body may lead to an increase in muscle mass and a decrease in bone density. This is a vicious cycle that can contribute to obesity.

In addition to its role in obesity, MIR5188 has also been shown to play a critical role in the regulation of muscle mass and bone density in individuals with normal weight. For example, studies have shown that MIR5188 levels are lower in individuals with normal weight compared to individuals with obesity. This suggests that MIR5188 may be a potential target for the treatment of obesity.

Furthermore, MIR5188 has also been shown to play a role in the development and progression of certain diseases associated with muscle mass and bone density, such as osteoporosis and certain cancers. This suggests that MIR5188 may also be a potential biomarker for these diseases.

In conclusion, MIR5188 is a protein that has been identified as a potential drug target and biomarker for obesity. Its role in the regulation of muscle mass and bone density, as well as its potential targets for the treatment of obesity and certain diseases, make it an attractive target for further research.

Protein Name: MicroRNA 5188

The "MIR5188 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR5188 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets